Response to "Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis"

Crit Care. 2020 Sep 29;24(1):591. doi: 10.1186/s13054-020-03308-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents
  • Betacoronavirus
  • COVID-19
  • Cohort Studies
  • Coinfection*
  • Coronavirus Infections*
  • Critical Illness*
  • Humans
  • Pandemics*
  • Pneumonia, Viral*
  • Prospective Studies
  • SARS-CoV-2

Substances

  • Anti-Bacterial Agents